FIELD: chemistry.
SUBSTANCE: invention relates to indol-3-yl-carbonyl-spiro-piperadine derivatives used as V1a receptor antagonists and which have formula I: 
, where the spiro-piperadine A head group and residues R1, R2 and R3 are as defined in claim 1 of the invention. The invention also pertains to pharmaceutical compositions which contain such compounds and use thereof in preparing medicines with V1a receptor antagonist activity.
EFFECT: high activity of derivatives.
37 cl, 1 tbl, 285 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDOLE-3-YL-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES | 2006 |
|
RU2420529C2 |
| INDOL-3-YL-CARBONYL-ASASPIRO DERIVATIVES AS VASOPRESSIN RECEPTOR ANTAGONISTS | 2006 |
|
RU2418801C2 |
| INDOLE-3-YL-CARBONYL-PIPERIDINE AND PIPERAZINE DERIVATIVES | 2006 |
|
RU2422442C2 |
| INDOL-3-YL-CARBONYL-PIPERADINE-BENZIMIDAZOLE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415139C2 |
| SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRA-AZA-BENZO[E]AZULENES | 2009 |
|
RU2514429C2 |
| SPIROINDOLINONE DERIVATIVES | 2007 |
|
RU2435771C2 |
| DERIVATIVES OF 1'-(2-HYDROXY-3-ARYLOXYPROPYL-1-YL)-SUBSTITUTED SPIRO[BENZOFURAN-PIPERIDINES], SPIRO[BENZOFURAN-PYRROLIDINES] AND SPIRO[CHROMEN-PIPERIDINES], METHOD FOR THEIR PREPARING, INTERMEDIATE COMPOUND AND METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITION, USING | 2003 |
|
RU2320664C2 |
| PYRROLO- AND THIAZOLOPYRIDINE COMPOUNDS (VERSIONS) AND BASED PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2461557C2 |
| NOVEL INDOLYSIN COMPOUNDS, METHOD FOR PRODUCING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2014 |
|
RU2693629C2 |
| METHOD OF PREPARING PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PATIENTS WITH ANXIETY STATE, PIPERIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PATIENTS WITH ANXIETY STATE OR EPILEPSY | 1992 |
|
RU2142952C1 |
